25 studies recruiting now13 research sites across CanadaJoin the community
Colds and influenza are different illnesses caused by different viruses. A cold builds slowly and stays in the nose and throat. Influenza arrives suddenly, with fever, aches and a tiredness that keeps you off your feet.
They are not mild and severe versions of the same thing. A cold can come from any of a large group of viruses: the Canadian Lung Association notes over a hundred, and a CMAJ review reports rhinovirus accounts for most cases. Influenza comes from influenza A and B, which change year to year, which is why a new vaccine is formulated each season.
Neither is a bacterial infection. The CMAJ review states that antibiotics have no beneficial effect on the common cold but do increase adverse events, and that only about 5 percent of diagnosed cases involve bacteria. The Public Health Agency of Canada reports that adults can spread influenza from the day before symptoms start until about five days after.
A cold announces itself over a day or so. A scratchy throat first, then sneezing, then a nose that runs and later blocks. The CMAJ review reports that adults have two to three colds a year and children under two have about six, that symptoms usually peak within one to three days, and that they last seven to ten days, occasionally stretching to three weeks. Most people keep going through it, feeling flat rather than floored.
Influenza runs on a different clock. The Public Health Agency of Canada gives the incubation period as usually two days, ranging from one to four, and the Saskatchewan Health Authority describes the onset as sudden. People can often name the hour they knew. Fever, chills, headache, aching muscles and joints, and a tiredness that puts them in bed. The worst of it usually eases over several days, but a cough and a flattened feeling can outlast everything else by weeks.
The distinction is worth making for three practical reasons. It changes what is likely to happen next, because influenza is what fills hospital beds in winter: 4,516 influenza hospitalisations were reported to Canada’s national surveillance system in the 2023 to 2024 season. It changes timing, because antiviral medicines for influenza are considered early in the illness rather than several days in. And it changes what you do around other people, since influenza spreads readily through households, workplaces and long-term care homes.
Cold symptoms can last up to two weeks; most influenza symptoms settle in five to seven days.
Some risk factors cannot be changed:
Others can often be worked on, usually with support from a health care team:
Canada’s National Advisory Committee on Immunization names the groups at high risk of influenza-related complications or hospitalisation in its statement for the 2026 to 2027 season: adults 65 and older, children aged 6 to 59 months, all pregnant people, residents of nursing homes and chronic care facilities, adults and children with chronic health conditions, and people from First Nations, Inuit or Metis communities.
The reasons are not the same for each group. Immune responses work differently at both ends of life, so very young children and older adults handle a new respiratory virus less easily. A chronic heart or lung condition leaves less reserve when an infection arrives, and influenza often makes an existing condition worse rather than simply adding a separate illness on top of it. Pregnancy changes lung capacity and immune function. Congregate living puts many people who are already at higher risk under one roof, which is why outbreaks in long-term care are watched closely. For First Nations, Inuit and Metis communities, the drivers named in Canadian public health work are access to care, distance from hospital services and housing conditions rather than anything inherent.
The committee recommends that influenza vaccine be offered annually to anyone 6 months of age or older who does not have a contraindication. Whether that fits your own situation, and which product, is a conversation for you and your clinician or pharmacist.
This is the part that puzzles most people. Vaccines for other illnesses are given once, or once a decade. Influenza vaccine is reformulated annually, and there is a reason for it.
Influenza A and B viruses copy themselves imperfectly. Small errors build up in the proteins on the surface of the virus, which are the parts your immune system learns to recognise. After a season or two, that surface has changed enough that antibodies built against the earlier version fit it less well. This gradual change is called antigenic drift, and it is why influenza returns every winter instead of running out of people to infect. Influenza A can also change more abruptly, when two different influenza viruses infect the same host and exchange whole segments of genetic material, which is how genuinely new strains appear.
Laboratories in a global surveillance network collect and characterise circulating viruses all year, including Canadian laboratories reporting to the Public Health Agency of Canada. The World Health Organization reviews that data and recommends seasonal influenza vaccine compositions twice a year, once for the northern hemisphere and once for the southern. Manufacturers then need months to produce and release doses, so the decision is made well before the season it is written for. The strains chosen are a forecast based on what is circulating at the time, not a description of what will circulate later.
Two things stack up. The viruses drift, so a formulation is written for one season rather than for good. And antibody levels raised by a previous season’s vaccine fall over the months that follow. That is why the National Advisory Committee on Immunization issues a fresh statement each year rather than a standing one.
Most are recognised from the pattern of symptoms, without any test. Where the answer changes what happens next, a nose or throat swab can be tested for influenza A and B, and usually for COVID-19 and respiratory syncytial virus too. That is done mainly for people in hospital, in long-term care, or at higher risk of complications. Canadian laboratories report results to the Public Health Agency of Canada’s surveillance programme, which is how the season-by-season figures are produced.
Most people recover at home, and care targets symptoms. A clinician or pharmacist may discuss:
Antibiotics act on bacteria, not the viruses behind colds and flu. What suits you is a decision for you and your own clinician.
Both illnesses are usually managed at home, and the aim is comfort while the illness runs its course. The Canadian Lung Association describes rest and fluids as the mainstay of cold self-care. Warm drinks ease a raw throat. Humid air, including steam from a shower, makes a blocked nose easier to live with. Eating less than usual for a day or two while you have a fever is common, and drinking enough matters more than eating normally.
For fever and aching, the CMAJ review identifies acetaminophen and anti-inflammatory medicines as helping with pain and fever. A pharmacist can say which over-the-counter products suit you, which matters if you take other medicines or live with heart, kidney or liver conditions. Many combination cold and flu products contain the same ingredients as the single-ingredient products beside them on the shelf, so it is worth reading both labels before taking them together.
Antiviral medicines are a different category. They act on the influenza virus itself rather than on symptoms, they are available only on prescription, and a clinician may discuss them for people at higher risk of complications or who are unwell enough to need hospital care. They are considered early in the illness rather than after several days, which is why being assessed soon after symptoms begin is what makes that conversation possible at all.
Staying home while you are feverish and unwell is also part of care, for the household, the workplace and anyone you would visit who is at higher risk.
There is no vaccine for the common cold and no medicine that reliably shortens one. The CMAJ review concluded that the evidence for preventing and treating the common cold is frequently of poor quality with inconsistent results. Influenza is a different problem: the viruses change from season to season, which is why the National Advisory Committee on Immunization issues a new statement every year. Research includes influenza vaccines designed to work across more strains and for longer, nasal spray vaccines, combination vaccines covering more than one respiratory virus, new antivirals, and faster tests that separate influenza, COVID-19 and RSV from bacterial infection. The committee also names exposure to avian influenza A(H5N1) as an area of attention.
Taking part is voluntary, informed consent comes first, you can stop at any time without affecting your regular care, and no one can say in advance whether a study will help you personally.
This page is written in plain language for people considering clinical research. It is general health information, not medical advice, and it does not replace a conversation with your own doctor or nurse practitioner.
Not always with certainty, but the pattern usually differs. The Canadian Lung Association describes cold symptoms appearing one to three days after infection, starting with a sore throat, sneezing and congestion, with mild aches and a run-down feeling. The Saskatchewan Health Authority describes influenza as having a sudden onset with fever, headache, muscle aches, joint pain, sore throat, tiredness and cough. Fever and body aches that arrive quickly point towards influenza, though the Public Health Agency of Canada notes fever may be absent in young children and older adults. A laboratory swab is the only way to know for sure, and it is usually reserved for people in hospital or at higher risk of complications.
Antibiotics act on bacteria, and colds and influenza are caused by viruses. The CMAJ review of the evidence on the common cold states that antibiotics have no beneficial effect on the common cold but do increase adverse events, and that only about 5 percent of clinically diagnosed cases involve a bacterial infection. If your clinician thinks a bacterial infection has developed on top of a viral one, that is a different situation and they will say so.
Because influenza viruses change from year to year, which is why Canada's National Advisory Committee on Immunization publishes a new statement each season rather than a permanent one. Research is working on vaccines that cover more strains and last longer, vaccines given as nasal sprays, combination vaccines for more than one respiratory virus, new antivirals, and faster tests. For colds there is no vaccine at all, and the CMAJ review concluded that the evidence on cold treatments is frequently of poor quality and inconsistent. Taking part in any study is voluntary, informed consent comes first, and you can withdraw at any time without affecting your regular care.
Because influenza A and B viruses change. Small errors accumulate in the surface proteins your immune system recognises, a gradual process called antigenic drift, so antibodies raised against an earlier version fit a later one less well. The World Health Organization reviews global surveillance data and recommends seasonal influenza vaccine compositions twice a year, once for each hemisphere, and manufacturers need months to produce doses. Antibody levels from a previous season also fall over the following months, which is why Canada's National Advisory Committee on Immunization publishes a fresh statement each season rather than a standing one.
Connecting Canadians with clinical research studies conducted by a network of physicians committed to advancing medicine — since 1995.
JoinAStudy.ca provides information about clinical research and does not provide medical advice, diagnosis, or treatment. Only a qualified study doctor can determine your eligibility for a study. Participation is always voluntary.
© 2026 JoinAStudy.ca · A network of Canadian physicians.|Designed by Pixelore.ca
